1. Ogawa A, Kondo K, Takei H, Fujisawa D, Ohe Y, Akechi T. Decision-Making Capacity for Chemotherapy and Associated Factors in Newly Diagnosed Patients with Lung Cancer. The oncologist. 2018;23(4):489-95. doi: 10.1634/theoncologist.2017-0187
2. Sakata N, Okumura Y, Fushimi K, Nakanishi M, Ogawa A. Dementia and Risk of 30-Day Readmission in Older Adults After Discharge from Acute Care Hospitals. Journal of the American Geriatrics Society. 2018 May;66(5):871-8. PubMed PMID: 29460284. doi: 10.1111/jgs.15282
3. Tanimukai H, Matsui T. Prevalence of cognitive impairments following chemotherapy and its relationship to depression in Japanese breast cancer survivors: an exploratory study. Int J Complement Alt Med. 2018.11(2):145-149
4. Taniguchi T, Tanimukai H, Hirai K, Tajime K. A Pilot Study of Barriers to Psychiatric Treatment among Japanese Healthcare Workers. Medical Science & Healthcare Practice.2018. 2(2):66-77
5. Kakusho Chigusa Nakajima-Ohyama, Okada A, Hayano E, Takimoto K, Ueki-Iwamoto C, Shizusawa Y, Tanimukai T. Efficacy and safety of gabapentin for delirium in Parkinson’s disease: A case series Jpn J Gen Hosp Psychiat. 2019.31(2) (in press)
6. Taniguchi T., Tanimukai H., Hirai K., Tajime K. A Pilot Study of Barriers to Psychiatric Treatment among Japanese Healthcare Workers, Medical Science & Healthcare Practice, 2, 2, 76-87, doi: 0.22158/mshp.v2n2p76
7. 小川朝生. 認知症の症状が進んできた段階における終末期ケアのあり方に関する調査研究事業 認知症の緩和ケア. 日本精神科病院協会雑誌. 2018/7/5;37(7):44-9
8. 小川朝生. 急性期病院入院患者、認知症合併で治療アウトカム低下-多職種で支援するための教育プログラムを開発. 月刊薬事. 2018/9/1;60(11):9-11
9. 小川朝生. 認知症がん患者への対応. 新薬と臨牀. 2018/11/10;67(11):62-9
10. 小川朝生. 認知症をもつがん患者に対する医学的判断と治療的介入. がん看護. 2019/1/1;24(1):5-8